October 25th, 2024

Biological therapies are substantially more complicated to manufacture than standard Rx prescription medications and in many cases have great clinical efficacy and very high cost. In 2025 Blue Shield of CA is introducing a special biosimilar partnership to to reduce costs for blockbuster drug Humira.
https://news.blueshieldca.com/2024/10/01/blue-shield-of-california-slashes-cost-of-worlds-best-selling-drug